Trident Texofab
Trident Texofab Share Price Chart
Trident Texofab last traded at ₹20.39 (2026-10-13). Over the past month the stock moved -11.6%, three months the stock moved -52.4%, year the stock moved -93.6%. Its closing range over 52 weeks is ₹20.00 – ₹371.45, with the latest close 94.5% below the high.
Closing prices up to 2026-10-13.
About Trident Texofab
Incorproated in 2008, Trident Texofab Ltd does manufacturing & wholesale trading of Textile Fabric Cloth[1]
Business Overview:[1][2] TTL operates as a semi-composite textile trading company with interests in manufacturing and trading of Home Furnishing, Garments, Technical Textiles and a variety of Polyester and Poly-blend Fabrics. It manufactures various grades of grey fabrics and also undertakes job work for Weaving, Digital Printing & Embroidery. Company procures polyester yarn, ink and fabric from the suppliers located in Surat and sells its product to the garment processing units in Surat, Panipat, Ahmedabad, and Mumbai
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Trident Texofab reported sales of ₹26.14 crore (-6.9%) and net profit of ₹0.52 crore (-49.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 26.14 | 1.42 | 5.43 | 0.52 | 0.35 |
| Mar 2026 | 33.57 | -1.08 | -3.22 | -2.01 | -1.34 |
| Dec 2025 | 25.74 | 1.64 | 6.37 | 0.57 | 0.38 |
| Sep 2025 | 30.63 | 2.48 | 8.10 | 1.13 | 0.75 |
| Jun 2025 | 28.08 | 2.07 | 7.37 | 1.02 | 0.68 |
| Mar 2025 | 38.21 | 1.35 | 3.53 | 0.51 | 0.38 |
| Dec 2024 | 31.69 | 2.32 | 7.32 | 0.30 | 0.29 |
| Sep 2024 | 26.45 | -0.27 | -1.02 | 1.00 | 0.99 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +14.0% | +37.7% | +26.6% | +9.2% | +15.8% | -18.8% | -12.1% | -6.9% |
| Operating profit growth | -121.4% | +22.1% | +32.4% | +36.2% | – | -29.3% | -180.0% | -31.4% |
| Net profit growth | +33.3% | -46.4% | – | +45.7% | +13.0% | +90.0% | -494.1% | -49.0% |
| EPS growth | +33.8% | -48.2% | – | -2.9% | -24.2% | +31.0% | -452.6% | -48.5% |
| OPM % | -1.0% | 7.3% | 3.5% | 7.4% | 8.1% | 6.4% | -3.2% | 5.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Trident Texofab reported sales of ₹118.00 crore (-3.3%) and net profit of ₹1.00 crore (-66.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 118.00 | 5.00 | 4.00 | 1.00 | 0.47 |
| Mar 2025 | 122.00 | 5.00 | 4.00 | 3.00 | 1.85 |
| Mar 2024 | 99.00 | 8.00 | 8.00 | 1.00 | 1.07 |
| Mar 2023 | 96.00 | 8.00 | 9.00 | 2.00 | 2.20 |
| Mar 2022 | 84.00 | 5.00 | 6.00 | 1.00 | 0.97 |
| Mar 2021 | 50.00 | 3.00 | 6.00 | 0.00 | 0.35 |
| Mar 2020 | 91.00 | 5.00 | 5.00 | 1.00 | 0.94 |
| Mar 2019 | 87.00 | 2.00 | 3.00 | 1.00 | 1.32 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +2.4% | +4.6% | -45.1% | +68.0% | +14.3% | +3.1% | +23.2% | -3.3% |
| Operating profit growth | +100.0% | +150.0% | -40.0% | +66.7% | +60.0% | +0.0% | -37.5% | +0.0% |
| Net profit growth | +0.0% | +0.0% | -100.0% | – | +100.0% | -50.0% | +200.0% | -66.7% |
| EPS growth | +69.2% | -28.8% | -62.8% | +177.1% | +126.8% | -51.4% | +72.9% | -74.6% |
| OPM % | 3.0% | 5.0% | 6.0% | 6.0% | 9.0% | 8.0% | 4.0% | 4.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Trident Texofab.
Get Free AI Stock Analysis FREE →Latest News
-
Trident Texofab appoints A Bafna & Associates as statutory auditor - scanx.trade
Frequently Asked Questions
What is Trident Texofab's current stock price?
Trident Texofab shares were last quoted at ₹20.39 (+2.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Trident Texofab?
Trident Texofab has a price-to-earnings (P/E) ratio of 153.57 and a price-to-book (P/B) ratio of 0.58. The industry P/E is 33.16.
What is the 52-week high and low of Trident Texofab?
The 52-week high of Trident Texofab is ₹379.00 and the 52-week low is ₹20.00.
What is the market cap of Trident Texofab?
The market capitalisation of Trident Texofab is about ₹32.24 crore.
How did Trident Texofab perform in its latest quarterly results?
In the latest quarter (Jun 2026), Trident Texofab reported sales of ₹26.14 crore (-6.9%) and net profit of ₹0.52 crore (-49.0%), compared with the same quarter last year.
Is Trident Texofab a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Trident Texofab has a 3-year ROE of 3.00%, 3-year profit growth of -17.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Trident Texofab?
Promoters hold about 32.16% of Trident Texofab.
Which sector does Trident Texofab belong to?
Trident Texofab belongs to the Trading sector.